SightLine Medical was founded with a simple but powerful vision: to stabilize and elevate ocular health. In a marketplace often defined by supply disruptions and shifting priorities, we anchor the availability of essential diagnostics—ensuring that doctors have what they need, when they need it. By strengthening this foundation, we restore clinicians to the center of the patient journey and empower them to deliver the highest standard of care.
Alongside our clinical solutions, SightLine develops Dedicated Brands—consumer-facing product families designed to extend the doctor’s care beyond the exam room. These products, from daily eye health supplements to ocular surface wellness solutions, provide patients with trusted, high-quality options recommended by their own clinicians. By aligning professional expertise with consumer access, we help bridge the gap between treatment and daily wellness, giving patients confidence and consistency in every step of their vision care.
Our executive team brings decades of experience in ophthalmic drug development, regulatory strategy, and operational leadership. United by a commitment to innovation and excellence, we drive SightLine’s mission forward with strategic vision and operational discipline.
With over 20 years of experience in ophthalmic pharmaceuticals, law, and corporate leadership, Travis leads SightLine’s clinical and commercial strategy. Previously CEO of Opus Life Sciences and EVP & General Counsel at Paragon BioTeck, he has guided companies through complex transactions, FDA development, and exponential growth. He holds J.D. and M.B.A. degrees.
Bill is an industry veteran with 40+ years of experience in ophthalmic CMC development, regulatory strategy, and quality systems. A founding partner of Module 3 Pharma Services, he has led efforts behind 15 NDAs and 30 INDs. He holds a Master’s in Microbiology and a BA in Chemistry.
Raj brings 25+ years of pharmaceutical, medical devices, and electronics operations experience in sourcing, ERP/WMS integrations, and 3PL strategies, at Paragon BioTeck, Opus Life Sciences, Kannact, Vetsource, and HP. He holds a Master’s in Chemical Engineering and a Master’s in Environmental Engineering.
Kristin specializes in GMP systems, regulatory submissions, and ISO compliance, with experience spanning pharma, devices, and supplements. At Opus and Paragon BioTeck, she led audits, regulatory strategy, and vendor quality oversight. She holds a BS in Biochemistry and is a certified ISO 13485 Lead Auditor.
Dr. Edward Paul, O.D., Ph.D., is one of America’s most recognized eye doctors and a leading expert in macular degeneration and ocular nutritional supplements. He is the researcher–developer behind TOZAL®, an enhanced AREDS2 formulation for age-related macular degeneration. An author of Conquering Macular Degeneration and 101 Great Ways to Health, and a medical contributor to several national magazines, Dr. Paul has also been featured on PBS, FOX, NBC, ABC, CBS, and Lifetime for his work in macular degeneration and low-vision rehabilitation.